JPRN-UMIN000017717招募中未知
Combination therapy of interferon-alpha and interleukin-2 for patients with metastatic renal cell carcinoma after failure of targeted therapy because of adverse events - IFN-alpha and IL-2 therapy after failure oftargeted therapy because of adverse events
Department of Urology, The University of Tokyo Hospital0 个研究点目标入组 30 人开始时间: 2015年5月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. allergic reaction for biological products such as vaccine 2. autoimmune hepatitis 3. interstitial pneumonitis 4. female during pregnancy or lactation 5. receiving steroid hormone therapy 6. progressive disease during prior targeted therapy
研究者
相似试验
已完成
不适用
Combination therapy using pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C virus (HCV) infection 3 to 120 months after liver transplantatioHepatitis C reinfection after liver transplantationInfections and InfestationsChronic viral hepatitisISRCTN51477478Hannover Medical School (Medizinische Hochschule Hannover) (Germany)75
招募中
3 期
Trial of novel combined therapy between interferon and hyperlipidemia for chronic hepatitis C patientschronic hepatitis type CJPRN-UMIN000005598Kyoto University Graduate School of Medicine Center for Genomic Medicine100
进行中（未招募）
1 期
Kombinationsbehandling med Interferon og JAK1-2 Hæmmer i behandlingen af Ph-Negativ Myeloprolifertiv CancerEUCTR2013-003295-12-DKRoskilde University Hospital50
尚未招募
2 期
Combination Therapy with Interferon-Alpha2a and Ruxolitinib in Newly Diagnosed Patients with Polycythemia Vera.
A Danish Safety and Efficacy Study.Polycythemia2024-518216-39-00Region Sjaelland25
已完成
2 期
Interferon alpha in combination with thalidomide in the treatment of metastatic renal cell carcinoma - a randomised phase II studyMetastatic renal cell carcinomaMalignant neoplasm of kidney, except renal pelvisCancerISRCTN11978947K Co-ordinating Committee for Cancer Research (UKCCCR)